柠檬苦素对哮喘幼年大鼠气道炎症的影响OA
Effect of limonin on airway inflammation in young rats with asthma
目的:探讨柠檬苦素(LIM)调节CCL2-CCR2信号通路对哮喘幼年大鼠气道炎症的影响.方法:取幼年SD大鼠以卵清蛋白诱导建立哮喘模型,随机分为模型组、LIM低剂量组、LIM高剂量组、地塞米松组、AAV-NC组、LIM高剂量+AAV-CCL2组和LIM高剂量+RS102895组,每组10只,另取10只幼年SD大鼠作为对照组,分组干预治疗后评测大鼠哮喘症状与肺功能,比较其哮喘评分、呼气峰流值(PEF)、0.3秒用力呼气容积(FEV0.3)/用力肺活量(FVC);吉姆萨染色检测支气管肺泡灌洗液(BALF)中炎症细胞并计数;HE染色检测肺组织病理形态,并进行气道炎症评分;ELISA测量BALF与血清中IL-5、IL-6、IL-13、TNF-α水平;流式细胞术检测脾脏和肺组织中Th1、Th2细胞比例;免疫印迹法检测肺组织CCL2、CCR2蛋白表达.将LIM与CCL2蛋白进行分子对接.结果:与模型组比较,LIM低、高剂量组和地塞米松组哮喘评分、气道炎症评分、嗜酸性粒细胞、巨噬细胞与淋巴细胞数量、IL-5、IL-6、IL-13、TNF-α、IL-4水平、Th2细胞比例、CCL2与CCR2蛋白表达降低,IFN-γ水平、PEF、FEV0.3/FVC、Th1细胞比例升高,且LIM高剂量组和地塞米松组各指标变化程度更大(P<0.05),但LIM高剂量组和地塞米松组间各指标差异无统计学意义(P>0.05).与LIM高剂量组比较,LIM高剂量+AAV-CCL2组各定量指标均呈相反趋势(P<0.05),LIM高剂量+RS102895组各定量指标进一步降低或升高(P<0.05).LIM与CCL2进行分子对接后的结合能为-7.03 kcal/mol,结合活性较好.结论:LIM可能通过阻止CCL2-CCR2信号通路激活而抑制炎症细胞因子表达释放,进而减轻哮喘幼年大鼠气道炎症,并改善其肺功能.
Objective:To investigate the effect of limonin(LIM)on airway inflammation in young rats with asthma by regulating CCL2-CCR2 signaling pathway.Methods:Young SD rats were induced with ovalbumin to establish an asthma model,and randomly divided into model group,low-dose LIM group,high-dose LIM group,dexamethasone group,AAV-NC group,high-dose LIM+AAV-CCL2 group and high-dose LIM+RS102895 group,with 10 rats in each group.Another 10 young SD rats were taken as control group.After grouping and intervention treatment,asthma symptoms and lung function of rats were evaluated,and their asthma scores,peak expiratory flow(PEF),and forced expiratory volume in 0.3 seconds(FEV0.3)/forced vital capacity(FVC)were compared.Inflammatory cells in bronchoalveolar lavage fluid(BALF)were classified and counted by Giemsa staining.HE staining was applied to detect patho-logical morphology of lung tissue,and their airway inflammation scores were compared.ELISA was applied to measure levels of IL-5,IL-6,IL-13 and TNF-α in BALF and serum.Flow cytometry was used to detect proportions of Th1 and Th2 cells in spleen and lung tissues.Western blot was applied to detect expressions of CCL2 and CCR2 proteins in lung tissues.Molecular docking of LIM with CCL2 protein was performed.Results:Compared with model group,asthma score,airway inflammation score,numbers of eosinophils,mac-rophages and lymphocytes,levels of IL-5,IL-6,IL-13,TNF-α,IL-4,proportion of Th2 cells,and expressions of CCL2 and CCR2 proteins were reduced in low-dose and high-dose LIM groups and dexamethasone group,while IFN-γ level,PEF and FEV0.3/FVC,proportion of Th1 cells were increased,and the changes in various indicators were greater in high-dose LIM group and dexamethasone group(P<0.05),there was no statistically significant difference in each index between high-dose LIM group and dexamethasone group(P>0.05).Compared with high-dose LIM group,all the quantitative indicators in high-dose LIM+AAV-CCL2 group showed an oppo-site trend(P<0.05),and the quantitative indicators in high-dose LIM+RS102895 group further decreased or increased(P<0.05).Binding energy of LIM and CCL2 after molecular docking was-7.03 kcal/mol,and the binding activity was good.Conclusion:LIM may inhibit expressions and release of inflammatory cytokines by blocking the activation of CCL2-CCR2 signaling pathway,thereby reducing airway inflammation and improving lung function in young rats with asthma.
单胜华;张茜;陈巾;陈超;游国叶
信阳职业技术学院,信阳 464000南阳市第一人民医院,南阳 473000河南科技大学第一附属医院,洛阳 471000信阳职业技术学院,信阳 464000信阳职业技术学院,信阳 464000
医药卫生
柠檬苦素CCL2-CCR2哮喘气道炎症肺功能
LimoninCCL2-CCR2AsthmaAirway inflammationLung function
《中国免疫学杂志》 2026 (5)
1069-1077,9
评论